213 Results | Everything | Search

New Products

View New Products (1)

Product TypeClear Filters

Analytical Chemistry (3)

Antibodies (14)

Assay & Reagent Kits (5)

Biochemicals (168)

Lipids (4)

Natural Products (18)

Proteins (9)

Small Molecule Modulators (166)

Research AreaClear Filters

Cancer (213)

Angiogenesis (15)

Autophagy (17)

Cell Cycle (32)

Cell Death (65)

Cell Migration & Metastasis (22)

Cell Signaling (213)

Abl family & Bcr-Abl Signaling (1)

ALK (Activin-like Kinase) Signaling (1)

ATM Signaling (1)

cAMP Signaling (2)

Casein Kinase Signaling (3)

DNA-PK Signaling (8)

ERK/MAPK Signaling (17)

Growth Factor Receptor Signaling (19)

GSK3 Signaling (2)

JAK/STAT Signaling (6)

JNK Signaling (4)

NF-κB Signaling (8)

Nitric Oxide Signaling (1)

p38 MAPK Signaling (1)

p53 Signaling (1)

PI3K/Akt/mTOR Signaling (213)

PKC Signaling (3)

ROCK Signaling (1)

S6K Signaling (3)

SRC Family Signaling (2)

DNA Damage and Repair (4)

Immunology (6)

Metabolism (4)

Multidrug Resistance (6)

Transcription Factors (13)

Tumor Microenvironment (6)

Cardiovascular System (13)

Cell Biology (84)

Endocrinology & Metabolism (21)

Epigenetics, Transcription, & Translation (11)

Immunology & Inflammation (38)

Infectious Disease (5)

Lipid Biochemistry (9)

Neuroscience (18)

Oxidative Stress & Reactive Species (7)

Plant Biology (1)

Xenobiotic Metabolism (2)

ApplicationClear Filters

Cell-Based Assay (2)

Click Chemistry (1)

ELISA (2)

Enzyme Activity (3)

High-Throughput Screening (5)

Immunocytochemistry (1)

Immunohistochemistry (12)

Immunoprecipitation (1)

Mass Spectrometry (2)

TR-FRET (5)

Western Blot (12)

Displaying 1 - 25 of 213 Results

Rapamycin

An allosteric inhibitor of mTORC1

CAS No. 53123-88-9

Item No. 13346

Formulation: A crystalline solid

Purity: ≥95%

AY 22989
NSC 226080
Sirolimus
Wy 090217

1 mg

$43

Add

5 mg

$108

Add

10 mg

$194

Add

25 mg

$429

Add

LY294002

A multi-kinase inhibitor

CAS No. 154447-36-6

Item No. 70920

Formulation: A crystalline solid

Purity: ≥98%

NSC 697286

5 mg

$31

Add

10 mg

$59

Add

25 mg

$108

Add

50 mg

$139

Add

Dorsomorphin

A potent, selective AMPK inhibitor

CAS No. 866405-64-3

Item No. 11967

Formulation: A crystalline solid

Purity: ≥98%

BML-275
Compound C

5 mg

$63

Add

10 mg

$107

Add

25 mg

$204

Add

50 mg

$377

Add

BYL719

An inhibitor of PI3Kα

CAS No. 1217486-61-7

Item No. 16986

Formulation: A crystalline solid

Purity: ≥98%

Alpelisib
NVP-BYL719

5 mg

$32

Add

10 mg

$58

Add

25 mg

$104

Add

50 mg

$128

Add

PI-103

A potent, cell-permeable PI3-kinase inhibitor

CAS No. 371935-74-9

Item No. 10009209

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$33

Add

5 mg

$125

Add

10 mg

$186

Add

25 mg

$347

Add

3-Methyladenine

An inhibitor of autophagy

CAS No. 5142-23-4

Item No. 13242

Formulation: A crystalline solid

Purity: ≥95%

3-MA
NSC 66389

25 mg

$37

Add

50 mg

$69

Add

100 mg

$128

Add

D-myo-Inositol-1,3,4,5,6-pentaphosphate (sodium salt)

An anticancer inositol phosphate

Item No. 10007784

Formulation: A lyophilized powder

Purity: ≥98%

Ins(1,3,4,5,6)P₅
1,3,4,5,6-IP₅

100 µg

$69

Add

500 µg

$297

Add

1 mg

$525

Add

Reversine

A purine derivative

CAS No. 656820-32-5

Item No. 10004412

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$40

Add

5 mg

$171

Add

10 mg

$302

Add

25 mg

$655

Add

Nimbolide

An anticancer phytochemical

CAS No. 25990-37-8

Item No. 19230

Formulation: A crystalline solid

Purity: ≥97%

NSC 309909

5 mg

$277

Add

25 mg

$1,164

Add

MK-2206 (hydrochloride)

An allosteric Akt inhibitor

CAS No. 1032350-13-2

Item No. 11593

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$48

Add

5 mg

$94

Add

10 mg

$117

Add

25 mg

$151

Add

Perifosine

An antitumor alkylphospholipid

CAS No. 157716-52-4

Item No. 10008112

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$41

Add

5 mg

$140

Add

10 mg

$196

Add

25 mg

$437

Add

Everolimus

A rapamycin derivative

CAS No. 159351-69-6

Item No. 11597

Formulation: A crystalline solid

Purity: ≥95%

RAD001

5 mg

$54

Add

10 mg

$97

Add

25 mg

$162

Add

50 mg

$270

Add

OSU03012

An anti-cancer celecoxib analog

CAS No. 742112-33-0

Item No. 10008005

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$81

Add

10 mg

$128

Add

50 mg

$553

Add

100 mg

$868

Add

NU 7026

Inhibitor of DNA-dependent protein kinase

CAS No. 154447-35-5

Item No. 13308

Formulation: A crystalline solid

Purity: ≥95%

DNA-PK Inhibitor II
LY293646

5 mg

$90

Add

10 mg

$168

Add

25 mg

$392

Add

50 mg

$696

Add

Triciribine

An Akt activation inhibitor and a prodrug form of triciribine phosphate

CAS No. 35943-35-2

Item No. 10010237

Formulation: A crystalline solid

Purity: ≥98%

API 2
NSC 154020
TCN
Tricyclic Nucleoside

1 mg

$52

Add

5 mg

$118

Add

10 mg

$182

Add

Akt Inhibitor VIII

A potent inhibitor of Akt1 and Akt2

CAS No. 612847-09-3

Item No. 14870

Formulation: A crystalline solid

Purity: ≥98%

500 µg

$32

Add

1 mg

$61

Add

5 mg

$141

Add

10 mg

$217

Add

NVP-BEZ235

A dual inhibitor of class I PI3Ks and mTOR

CAS No. 915019-65-7

Item No. 10565

Formulation: A crystalline solid

Purity: ≥98%

Dactolisib

25 mg

$49

Add

50 mg

$86

Add

100 mg

$152

Add

250 mg

$259

Add

PKC 412

Kinase inhibitor with potential use in cancer treatment

CAS No. 120685-11-2

Item No. 10459

Formulation: A crystalline solid

Purity: ≥98%

N-Benzoylstaurosporine
CGP 41231
CGP 41251
Midostaurin

1 mg

$31

Add

5 mg

$93

Add

10 mg

$154

Add

25 mg

$270

Add

INK128

Inhibitor of TORC1/2

CAS No. 1224844-38-5

Item No. 11811

Formulation: A crystalline solid

Purity: ≥98%

MLN0128

1 mg

$28

Add

5 mg

$49

Add

10 mg

$83

Add

50 mg

$275

Add

Rapamycin-d₃

An internal standard for the quantification of rapamycin

CAS No. 392711-19-2

Item No. 22093

Formulation: A 1 mg/ml solution in ethanol

Purity: ≥98% deuterated forms (d₁-d₃)

Sirolimus-d₃

500 µg

$134

Add

1 mg

$202

Add

Protocatechuic Acid

A phenolic compound with antioxidant, anti-inflammatory, and anticancer properties

CAS No. 99-50-3

Item No. 14916

Formulation: A crystalline solid

Purity: ≥98%

NSC 16631
PCA

25 g

$49

Add

50 g

$86

Add

100 g

$152

Add

AZD 8055

A potent mTOR inhibitor

CAS No. 1009298-09-2

Item No. 16978

Formulation: A crystalline solid

Purity: ≥98%

CCG-168

1 mg

$49

Add

5 mg

$96

Add

10 mg

$143

Add

50 mg

$423

Add

D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt)

An anticancer inositol phosphate

Item No. 10009851

Formulation: A lyophilized powder

Purity: ≥98%

Ins(1,3,4,5,6)P₅
1,3,4,5,6-IP₅ (sodium salt)

100 µg

$69

Add

500 µg

$297

Add

1 mg

$525

Add

740 Y-P (trifluoroacetate salt)

A PI3K activator

Item No. 22598

Formulation: A crystalline solid

Purity: ≥85%

Y-P 740

500 µg

$134

Add

1 mg

$253

Add

AZD 5363

A pan-Akt inhibitor

CAS No. 1143532-39-1

Item No. 15406

Formulation: A crystalline solid

Purity: ≥98%

Capivasertib

1 mg

$54

Add

5 mg

$149

Add

10 mg

$270

Add

25 mg

$472

Add

Displaying 1 - 25 of 213 Results

Cart Subtotal:$0

New Products

Product TypeClear Filters

Research AreaClear Filters

ApplicationClear Filters

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A lyophilized powder

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥97%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A 1 mg/ml solution in ethanol

Purity: ≥98% deuterated forms (d1-d3)

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A lyophilized powder

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥85%

Formulation: A crystalline solid

Purity: ≥98%

Purity: ≥98% deuterated forms (d₁-d₃)